Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Huvudupphovsman: | Hoque, Ismoth Ara |
---|---|
Övriga upphovsmän: | Azam, Faruque |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2024
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/23164 |
Liknande verk
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
av: Paul, Pulock
Publicerad: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
av: Rahman, Tasnim
Publicerad: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
av: Karim, Samia Binte
Publicerad: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
av: Flora, Sanzida Alam
Publicerad: (2024) -
Molecules associated with the development of lung cancer
av: Rahman, Adree, et al.
Publicerad: (2023)